Charles Schwab’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,072
| Closed | -$21.2K | – | 3520 |
|
|
2024
Q2 | $21.2K | Sell |
17,072
-74,459
| -81% | -$92.3K | ﹤0.01% | 3584 |
|
|
2024
Q1 | $173K | Sell |
91,531
-14,160
| -13% | -$26.8K | ﹤0.01% | 3254 |
|
|
2023
Q4 | $279K | Buy |
105,691
+9,611
| +10% | +$25.4K | ﹤0.01% | 3228 |
|
|
2023
Q3 | $221K | Hold |
96,080
| – | – | ﹤0.01% | 3266 |
|
|
2023
Q2 | $351K | Buy |
96,080
+69,996
| +268% | +$255K | ﹤0.01% | 3194 |
|
|
2023
Q1 | $93.1K | Buy |
26,084
+13,432
| +106% | +$48K | ﹤0.01% | 3261 |
|
|
2022
Q4 | $36.1K | Hold |
12,652
| – | – | ﹤0.01% | 3425 |
|
|
2022
Q3 | $29K | Hold |
12,652
| – | – | ﹤0.01% | 3439 |
|
|
2022
Q2 | $32K | Sell |
12,652
-68,398
| -84% | -$173K | ﹤0.01% | 3457 |
|
|
2022
Q1 | $396K | Hold |
81,050
| – | – | ﹤0.01% | 3148 |
|
|
2021
Q4 | $917K | Buy |
81,050
+2,820
| +4% | +$31.9K | ﹤0.01% | 2948 |
|
|
2021
Q3 | $1.14M | Sell |
78,230
-121,330
| -61% | -$1.77M | ﹤0.01% | 2825 |
|
|
2021
Q2 | $2.33M | Buy |
199,560
+6,893
| +4% | +$80.3K | ﹤0.01% | 2663 |
|
|
2021
Q1 | $2.35M | Buy |
192,667
+8,246
| +4% | +$101K | ﹤0.01% | 2617 |
|
|
2020
Q4 | $2.31M | Sell |
184,421
-6,194
| -3% | -$77.5K | ﹤0.01% | 2553 |
|
|
2020
Q3 | $2.87M | Buy |
190,615
+101,956
| +115% | +$1.53M | ﹤0.01% | 2355 |
|
|
2020
Q2 | $2.17M | Buy |
88,659
+38,272
| +76% | +$938K | ﹤0.01% | 2392 |
|
|
2020
Q1 | $715K | Buy |
50,387
+195
| +0.4% | +$2.77K | ﹤0.01% | 2585 |
|
|
2019
Q4 | $797K | Buy |
50,192
+1,546
| +3% | +$24.5K | ﹤0.01% | 2672 |
|
|
2019
Q3 | $411K | Buy |
48,646
+2,837
| +6% | +$24K | ﹤0.01% | 2878 |
|
|
2019
Q2 | $412K | Hold |
45,809
| – | – | ﹤0.01% | 2899 |
|
|
2019
Q1 | $355K | Buy |
45,809
+12,709
| +38% | +$98.5K | ﹤0.01% | 2887 |
|
|
2018
Q4 | $156K | Hold |
33,100
| – | – | ﹤0.01% | 3045 |
|
|
2018
Q3 | $300K | Hold |
33,100
| – | – | ﹤0.01% | 3000 |
|
|
2018
Q2 | $393K | Buy |
33,100
+16,800
| +103% | +$199K | ﹤0.01% | 2872 |
|
|
2018
Q1 | $230K | Buy |
+16,300
| New | +$230K | ﹤0.01% | 2956 |
|